Chlamydia pneumoniae infection and incident coronary heart disease. The atherosclerosis risk in communities study

American Journal of Epidemiology

Volumn 150, Issue 2, 1999, Pages 149-156

  Nieto, F Javier ^a   Folsom, Aaron R ^b   Sorlie, Paul D ^c   Grayston, J Thomas ^d   Wang, San Pin ^d   Chambless, Lloyd E ^e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e IL   (United States)

Author keywords

Atherosclerosis; Chlamydia pneumoniae; Cohort studies; Coronary disease; Smoking

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CIGARETTE SMOKING; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT;

EID: 0033565347     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009974     Document Type: Article

References (53)

1. Saikku P, Wang SP, Kleemola M, et al. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis 1985;151:832-9.
2. Grayston JT, Kuo CC, Wang SP, et al. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory infections. N Engl J Med 1986;315:161-8.
3. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-25.
4. Grayston JT, Kuo CC, Campbell LA, et al. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J 1993; 14(suppl K):66-71.
5. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992;25(suppl 1):27-34.
6. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158-61.
7. Kuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
8. Kuo CC, Gown AM, Benditt EP, et al. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Atheroscler Thromb 1993;13:1501-4.
9. Kuo CC, Grayston JT, Campbell LA, et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995;92:6911-14.
10. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
11. Grayston JT, Kuo CC, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
12. Blasi F, Denti F, Erba M, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996;34:2766-9.
13. Ong G, Thomas BJ, Mansfield AO, et al. Detection and wide-spread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996;49: 102-6.
14. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27: 1555-61.
15. Chiu B, Viira E, Tucker W, et al. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;96:2144-8.
16. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 1996;125:979-82.
17. Weiss SM, Roblin PM, Gaydos CA, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996;173:957-62.
18. Kaukoranta-Tolvanen S-S, Laitinen K, Saikku P, et al. Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog 1994;16:313-19.
19. Godzik KL, O'Brien ER, Wang S-K, et al. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995;33:2411-14.
20. Kark JD, Leinonen M, Paltiel O, et al. Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. Int J Epidemiol 1997;26:730-8.
21. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
22. Thom DH, Wang S-P, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991;11: 547-51.
23. Linnanmäki E, Leinonen M, Mattila K, et al. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993;87:1130-4.
24. Mendall MA, Carrington D, Strachan D, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995;30:121-8.
25. Blasi F, Cosentini R, Raccanelli R, et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest 1997;112:309-12.
26. Mazzoli S, Tofani N, Fantini A, et al. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. Am Heart J 1998;135:15-20.
27. Wimmer ML, Sandmann-Strupp R, Saikku P, et al. Association of chlamydial infection with cerebrovascular disease. Stroke 1996;27:2207-10.
28. Melnick SL, Shahar E, Folsom AR, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med 1993;95:499-504.
29. Wissler RW. Significance of Chlamydia pneumoniae (TWAR) in atherosclerotic lesions. (Editorial). Circulation 1995;92:3376.
30. Gupta S, Leatham EW. The relation between Chlamydia pneumoniae and atherosclerosis. (Editorial). Heart 1997;77:7-8.
31. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997;350:430-6.
32. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116: 273-8.
33. Miettinen H, Lehto S, Saikku P, et al. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin-dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 1996;17:682-8.
34. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
35. Gurfinkel E, Bozovich G, Daroca A, et al. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997;350:404-7.
36. Laitinen K, Laurila A, Pyhälä L, et al. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 1997;65:4832-5.
37. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
38. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702.
39. White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996;49:223-33.
40. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification. Littleton, MA: John Wright, 1982.
41. Pignoli P, Tremoli E, Poli A, et al. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-406.
42. Siedel J, Hägele EO, Ziegenhorn J, et al. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-80.
43. Shah BV, Folsom RE, La Vengue LM, et al. Statistical methods and mathematical algorithms used in SUDAAN. Research Triangle Park, NC: Research Triangle Institute, 1993.
44. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994;50:1064-72.
45. Vandenbroucke JP. Chlamydia TWAR and acute myocardial infarction. (Letter). Lancet 1989;1:158.
46. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscler Thromb 1992;12:945-7.
47. Karvonen M, Tuomilehto J, Pitkäniemi J, et al. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 1994;23:1315-21.
48. Thom DH, Grayston JT, Siscovick DS, et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268: 68-72.
49. Hahn DL. Chlamydia, smoking, and heart disease. (Letter). Ann Intern Med 1992;117:171.
50. Saikku P, Leinonen M, Tenkanen L. Chlamydia, smoking, and heart disease. (Letter). Ann Intern Med 1992;117:171.
51. Lip GY, Beevers G. Can we treat coronary artery disease with antibiotics? (Editorial). Lancet 1997;350:378-9.
52. Grayston JT. Chlamydia in atherosclerosis. (Editorial). Circulation 1993;87:1408-9.
53. Nieto FJ. Infections and atherosclerosis: new clues from an old hypothesis? Am J Epidemiol 1998;148:937-48.